Pfizer Inc Income Statement Quarterly
PFE
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
INCOME STATEMENT (Quarterly GAAP In millions $) |
(Dec 31 2023) IV. Quarter |
(Oct 01 2023) III. Quarter |
(Jul 02 2023) II. Quarter |
(Apr 02 2023) I. Quarter |
(Dec 31 2022) IV. Quarter |
Revenue From Contract With Customer Excluding Assessed Tax |
|
- |
- |
- |
|
Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer |
|
- |
- |
- |
|
Total Revenue |
14,248.00 |
13,232.00 |
12,734.00 |
18,282.00 |
24,289.00 |
Cost of Goods and Services Sold |
7,562.00 |
9,269.00 |
3,237.00 |
4,886.00 |
9,649.00 |
Gross
Profit |
6,686.00 |
3,963.00 |
9,497.00 |
13,396.00 |
14,640.00 |
Selling, Administration, Marketing |
4,575.00 |
3,281.00 |
3,497.00 |
3,418.00 |
4,645.00 |
Depriciation & Amortization |
1,267.00 |
1,179.00 |
1,184.00 |
1,103.00 |
1,130.00 |
Research & development |
2,815.00 |
2,711.00 |
2,648.00 |
2,505.00 |
3,616.00 |
Restructuring Charges AndAcquisition Related Costs |
2,565.00 |
155.00 |
214.00 |
9.00 |
795.00 |
Other exp. /-income |
- |
- |
- |
- |
- |
Special Items |
- |
- |
- |
- |
- |
Total operating costs including COS |
18,784.00 |
16,595.00 |
10,780.00 |
11,921.00 |
19,835.00 |
Operating income/-loss
|
-4,536.00 |
-3,363.00 |
1,954.00 |
6,361.00 |
4,454.00 |
Other Deductions / - Income |
Interest expense |
- |
- |
- |
- |
- |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
- |
- |
- |
- |
- |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Income from affiliates |
- |
- |
- |
- |
- |
Minority interest |
- |
- |
- |
- |
- |
Financing Loss/ -Income |
- |
- |
- |
- |
- |
Other loss/ -income |
-407.00 |
-11.00 |
-315.00 |
91.00 |
-777.00 |
Total costs & expenses |
18,377.00 |
16,584.00 |
10,465.00 |
12,012.00 |
19,058.00 |
Income /-loss before income taxes |
-4,129.00 |
-3,352.00 |
2,269.00 |
6,270.00 |
5,231.00 |
Income taxes expenses/-benefit |
-795.00 |
-964.00 |
-71.00 |
715.00 |
230.00 |
Income after income taxes |
-3,335.00 |
-2,388.00 |
2,340.00 |
5,555.00 |
5,000.00 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
-3,334.00 |
-2,388.00 |
2,340.00 |
5,555.00 |
5,001.00 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
-26.00 |
12.00 |
-2.00 |
1.00 |
2.00 |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
-3,360.00 |
-2,376.00 |
2,338.00 |
5,556.00 |
5,003.00 |
Noncontrolling interests |
9.00 |
6.00 |
11.00 |
13.00 |
8.00 |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-3,369.00 |
-2,382.00 |
2,327.00 |
5,543.00 |
4,994.00 |
EBIT |
-4,129.00 |
-3,352.00 |
2,269.00 |
6,270.00 |
5,231.00 |
EBITD |
-2,459.00 |
-1,792.00 |
3,842.00 |
7,757.00 |
6,750.00 |
EBITDA |
-2,459.00 |
-1,792.00 |
3,842.00 |
7,757.00 |
6,750.00 |
Per
Share (GAAP Quarterly, in $) |
(Dec 31 2023) IV. Quarter |
(Oct 01 2023) III. Quarter |
(Jul 02 2023) II. Quarter |
(Apr 02 2023) I. Quarter |
(Dec 31 2022) IV. Quarter |
Basic EPS (excl. extra
items) |
-0.59 |
-0.42 |
0.41 |
0.98 |
0.89 |
Extraordinary items |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
Basic Net EPS |
-0.60 |
-0.42 |
0.41 |
0.98 |
0.89 |
Basic shares outstanding (Mill.
of Units) |
5,646.00 |
5,646.00 |
5,646.00 |
5,634.00 |
5,615.00 |
EPS other shares |
- |
- |
- |
- |
- |
Diluted Net EPS |
-0.59 |
-0.42 |
0.41 |
0.97 |
0.87 |
Diluted average shares (Mill.
of Units) |
5,727.03 |
5,646.00 |
5,713.00 |
5,727.00 |
5,735.28 |
Dividend per share |
0.404 |
0.41 |
0.405 |
0.402 |
0.391 |
|
|